FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

BioCircuit Technologies 510(k) for Nerve Tape

FDA clears a BioCircuit Technologies 510(k) for its nerve repair device, Nerve Tape, a sutureless option for surgical repair of transected nerves.

Federal Register

Draft Guide on Dose Banding in Labeling

Federal Register notice: FDA makes available a draft guidance entitled Human Prescription Drug and Biological Products Labeling for Dosing Based on W...

Federal Register

Orange Book Therapeutic Equivalence Guide

Federal Register notice: FDA has made available a draft guidance entitled Evaluation of Therapeutic Equivalence that explains how it evaluates generic...

Medical Devices

New Renuvion/J-Plasma Handpiece Available: FDA

FDA says it has cleared the Renuvion APR Handpiece for specific subcutaneous dermatological and esthetic procedures.

Human Drugs

Whitmer Wants Mifepristone REMS Lifted

Michigan Gov. Gretchen Whitmer urges FDA to eliminate all REMS restrictions from the mifepristone abortion drug.

Medical Devices

AdvaMed Supports Diagnostics Reforms in User Fee Reauthorization

The Advanced Medical Technology Association urges the House and Senate to come to terms on a FDA user fee reauthorization package that includes diagno...

Federal Register

Panel to Discuss Certain Accelerated Approvals

Federal Register notice: FDA announces a 9/22-23 Oncologic Drugs Advisory Committee meeting that will discuss an NDA for Spectrum Pharmaceuticals pozi...

Federal Register

Topical Xylocaine Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Fresenius Kabis Xylocaine (lidocaine hydrochloride) topical solution 4% was not withdrawn from sale due t...

Human Drugs

Therapeutic Equivalence Evaluation Guidance

FDA publishes a draft guidance on therapeutic equivalence evaluations.

Human Drugs

Comments on ICH Quality Risk Management Guidance

Five stakeholders recommend changes to an International Council for Harmonization revised quality risk management guidance.